<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> have transformed the prognosis of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), but no further advance has been achieved during the last few years </plain></SENT>
<SENT sid="1" pm="."><plain>Treatment of SLE rests on the use, as rational as possible, of those therapeutic tools that are available </plain></SENT>
<SENT sid="2" pm="."><plain>However, diagnosing SLE does not necessary, they must be given promptly in effective doses whilst preventing their side-effects, notably by the simultaneous management of atheroma factors </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="35475">Non-steroidal anti-inflammatory agents</z:chebi> and synthetic <z:chebi fb="1" ids="38068">antimalarial</z:chebi> drugs may be used to replace <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> or reduce their dosage </plain></SENT>
<SENT sid="4" pm="."><plain>Severe forms of SLE which are function- or life-threatening require <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi>, the best one being <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> administered monthly as intravenous bolus injections, as this drug has been shown to be effective and to have low morbidity </plain></SENT>
<SENT sid="5" pm="."><plain>Plasmapheresis is exceptionally needed </plain></SENT>
<SENT sid="6" pm="."><plain>The risk of thrombogenesis due to the frequently associated "<z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>" can be avoided by <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> or antiplatelets the respective indications of which have not yet been clearly determined </plain></SENT>
<SENT sid="7" pm="."><plain>SLE being a <z:hpo ids='HP_0011010'>chronic</z:hpo> disease, patient's compliance with treatment is very important and justifies the efforts made to train and inform these young male or female patients </plain></SENT>
</text></document>